(Q51762995)

11 April 2018

MDMA

0 references

title

Major depression: the relative contribution of gender, MDMA, and cannabis use. (English)

1 reference

11 April 2018

author name string

Heather Durdle

1

1 reference

11 April 2018

Leslie H Lundahl

2

1 reference

11 April 2018

Chris-Ellyn Johanson

3

1 reference

11 April 2018

Manuel Tancer

4

1 reference

11 April 2018

publication date

1 January 2008

1 reference

11 April 2018

published in

Depression and Anxiety

1 reference

11 April 2018

volume

25

1 reference

11 April 2018

issue

3

1 reference

11 April 2018

page(s)

241-247

1 reference

11 April 2018

Cannabis abuse as a risk factor for depressive symptoms

cites work

1 reference

7 January 2021

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

1 reference

7 January 2021

Exploring the association between cannabis use and depression.

1 reference

7 January 2021

Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender

1 reference

7 January 2021

Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio

1 reference

7 January 2021

Mood state and brain electric activity in ecstasy users.

1 reference

7 January 2021

No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study

1 reference

7 January 2021

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.

1 reference

7 January 2021

Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults

1 reference

7 January 2021

Recreational ecstasy use and depression

1 reference

7 January 2021

Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study

1 reference

7 January 2021

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

1 reference

7 January 2021

Mental disorders in ecstasy users: a prospective-longitudinal investigation

1 reference

7 January 2021

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

1 reference

7 January 2021

Chronic MDMA (ecstasy) use, cognition and mood.

1 reference

7 January 2021

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

1 reference

7 January 2021

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

1 reference

7 January 2021

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

1 reference

7 January 2021

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects

1 reference

7 January 2021

Relationship between ecstasy use and depression: a study controlling for poly-drug use.

1 reference

7 January 2021

Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis

1 reference

7 January 2021

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

1 reference

7 January 2021

Mental disorders in current and former heavy ecstasy (MDMA) users

1 reference

7 January 2021

Cognitive performance and serotonergic function in users of ecstasy.

1 reference

7 January 2021

Depression and gender. An international review

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20297

1 reference

11 April 2018

1 reference

11 April 2018